Cite
HARVARD Citation
Kameswaran, M. et al. (n.d.). Preclinical evaluation of 131I-Bevacizumab – A prospective agent for radioimmunotherapy in VEGF expressing cancers. Applied radiation and isotopes. pp. 109-113. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kameswaran, M. et al. (n.d.). Preclinical evaluation of 131I-Bevacizumab – A prospective agent for radioimmunotherapy in VEGF expressing cancers. Applied radiation and isotopes. pp. 109-113. [Online].